Helal
Abdelsalam Helal, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20110154375 | MODULAR PLATFORM ENABLING HETEROGENEOUS DEVICES, SENSORS AND ACTUATORS TO INTEGRATE AUTOMATICALLY INTO HETEROGENOUS NETWORKS - A system includes a hardware platform, at least one driver, a plurality of devices connected to the hardware platform, a middleware interface, and a plurality of software services. Each of the plurality of devices is selected from the group consisting of sensors and actuators. The plurality of software services is generated by the at least one driver, wherein a software service associates with a device, and wherein each of the software services complies with the middleware interface. A method for interfacing a plurality of devices to a hardware platform includes communicably connecting each of the plurality of devices to the hardware platform, converting each of the plurality of devices into a programmable software service using a driver, and programming each of the software services to comply with a middleware interface. | 06-23-2011 |
Abdelsalam A. Helal, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20100157947 | System, Apparatus, and Methods for Proactive Allocation of Wireless Communication Resources - A system for communication between a mobile node and a communications network is provided for use with a communications network having one or more communications network nodes that define a foreign agents and that communicate with the mobile node in a predefined region. The system includes a ghost-foreign agent that advertises a foreign agent so that the mobile node is aware of the foreign agent when the mobile node is located outside the predefined region. The system further includes a ghost-mobile node that signals the foreign agent in response to the foreign agent advertising and based upon a predicted future state of the mobile node. | 06-24-2010 |
Ahmed Helal, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150155585 | GRAVITY INDUCED FLOW CELL - Gravity induced flow cell. The flow cell includes first and second reservoirs having a selected volume containing a flowable redox electrode. A membrane separates charged and discharged material. An energy-extraction region includes electronically conductive porous current collectors through or adjacent to which the flowable redox electrodes flow and to which charge transfer occurs. Structure is provided for altering orientation of the flow cell whereby gravity induces flow of the flowable redox electrode between the first and second reservoirs to deliver power. By varying the angle of the cell, flow rate and power delivered on discharge or the charge rate on charge may be varied. | 06-04-2015 |
Chris John Helal, Mystic, CT US
Patent application number | Description | Published |
---|---|---|
20150291625 | Heteroaromatic Compounds and their Use as Dopamine D1 Ligands - The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof and N-oxides thereof; processes and intermediates for preparation of; and compositions and uses thereof. The present invention further provides D1 agonists with reduced D1R desensitization, D1 agonists with a reduced β-arrestin recruitment activity relative to Dopamine, D1 agonists interacting significantly with the Ser188 but not significantly with the Ser202 of a D1R when binding to the D1R, D1 agonists interacting less strongly with the Asp103 and interacting less strongly with the Ser198 of a D1R when binding to the D1R, and their uses. | 10-15-2015 |
Christopher J. Helal, Mystic, CT US
Patent application number | Description | Published |
---|---|---|
20110224231 | Novel Lactams as Beta Secretase Inhibitors - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment methods of synthesis, and intermediates are also disclosed. | 09-15-2011 |
20120142729 | KAT ll INHIBITORS - The present invention relates to compounds 3-amino-1-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline-7-carbonitrile, 3-amino-1-hydroxy-7-(2-methoxyethoxy)-3,4-dihydroquinolin-2(1H)-one, and 3-amino-1-hydroxy-7-[(1S)-2-methoxy-1-methylethoxy]-3,4-dihydroquinolin-2(1H)-one, including racemic mixtures and resolved enantiomers thereof, to pharmaceutically acceptable salts thereof, and to the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans. | 06-07-2012 |
Christopher J. Helal, East Lyme, CT US
Patent application number | Description | Published |
---|---|---|
20080214607 | HETEROAROMATIC QUINOLINE COMPOUNDS - The invention pertains to heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds which are selective inhibitors of PDE10. The invention also relates to intermediates for preparation of said compounds; pharmaceutical compositions comprising said compounds; and the use of said compounds in a method for treating certain central nervous system (CNS) or other disorders. | 09-04-2008 |
20100190771 | AMINO-HETEROCYCLIC COMPOUNDS - The invention provides PDE9-inhibiting compounds of Formula (I), | 07-29-2010 |
Christopher John Helal, Mystic, CT US
Patent application number | Description | Published |
---|---|---|
20120214791 | Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders - The present invention relates to compounds of the Formula | 08-23-2012 |
20120329777 | Amino-Heterocyclic Compounds - The invention provides PDE9-inhibiting compounds of Formula (I), | 12-27-2012 |
20130053373 | Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, | 02-28-2013 |
20130150376 | Novel Sultam Compounds - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. | 06-13-2013 |
20140066622 | Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders - The present invention relates to compounds of the Formula | 03-06-2014 |
20140080806 | PYRAZOLO[3,4-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE2 INHIBITORS AND/OR CYP3A4 INHIBITORS - The present invention provides, inter alia, compounds of Formula (I) and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal. The present invention further provides compounds of Formula (Id) and pharmaceutically acceptable salts thereof as CYP3A4 selective inhibitors. | 03-20-2014 |
20140088081 | Amino-Heterocyclic Compounds - The invention provides PDE9-inhibiting compounds of Formula (I), | 03-27-2014 |
20140329820 | Triazine Derivatives - The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R | 11-06-2014 |
20150080401 | Triazine Derivatives - The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R | 03-19-2015 |
20150087637 | Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds - Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, | 03-26-2015 |
Christopher John Helal, East Lyme, CT US
Patent application number | Description | Published |
---|---|---|
20080206137 | 11C-Labeled Benzyl-Lactam Compounds and Their Use as Imaging Agents - The invention relates to “C-labeled compounds, their preparation, compositions comprising an effective amount of a “C-labeled compound, and the use of a “C-labeled compound as a radiopharmaceutical for positron emission tomography. | 08-28-2008 |
Mohamed Helal, Toronto CA
Patent application number | Description | Published |
---|---|---|
20150101175 | AUTOMATED PERCUSSIVE RIVETING SYSTEM - A fastener carrier for fasteners for use in a riveting system, said carrier comprising at least one holding zone and at least one release zone, wherein said holding zone holds a fastener in a stored position and said release zone releases said fastener from said carrier, said holding zone having a diameter smaller than said release zone. | 04-16-2015 |
Mohamed Helal, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20090030902 | SCHEMATIZED DATA INTELLIGENT ASSISTANCE FOR DEVELOPMENT ENVIRONMENTS - Intelligent assistance functionality is provided in development environments and/or other editors for schematized data. Input of a trigger character sequence can initiate an intelligent assistance box having data corresponding to a related schema. Thus, the intelligent assistance data can be dynamic as schematized data can change; the data can be queried from the schema as requested to facilitate this end. In one embodiment, the data can be an extensible markup language (XML) schema having a plurality of elements. In this regard, syntax can be entered into a development environment to effectuate an intelligent assistance box comprising the elements of the schema; a root level element can be displayed for an initial trigger character sequence. After selecting the element, another trigger sequence can be input to facilitate querying the schema for next level elements, and so on. | 01-29-2009 |
20130198171 | METHOD AND SYSTEM FOR MANAGING DATABASE OBJECT INFORMATION - A method for processing a database object information request includes receiving a database object information request. The database object information request includes a session initiation request and a database object schema retrieval request. The method further includes opening a database object information retrieval session, including assigning a session identifier to the database object information retrieval session, retrieving a result set corresponding to the database object information request, further including assigning a moniker to the result set for use in subsequent database object information retrieval, retrieving the requested database object information using the session identifier and the moniker, and providing a database object information response, the database object information response including the requested database object information. | 08-01-2013 |
Mohamed Hany Abdulwahab Mosilhy Helal, Jeddah SA
Patent application number | Description | Published |
---|---|---|
20150099751 | IN SITU GEL LOADED WITH PHOSPHODIESTERASE TYPE V INHIBITORS NANOEMULSION - The in situ gel loaded with phosphodiesterase Type V (PDE5) inhibitors nanoemulsion was prepared using an innovative approach to reformulate the PDE5 inhibitors in a nanoemulsion, and then loading the nanoemulsion into an in situ gel base. These preparations are administered by intramuscular injection in order to give a depot effect for a period of time that exceeds 15 days. The in situ gel composition gives slow, controlled release of the PDE5 inhibitor. The in situ gel composition is useful for prophylaxis and treatment of some important chronic diseases, such as diabetic complications, benign prostatic hyperplasia, erectile dysfunction, and diseases associated with endothelial dysfunction. | 04-09-2015 |
Mohamed Mohsen Elsayed Hassan Helal, Kirkland, WA US
Patent application number | Description | Published |
---|---|---|
20140074891 | GENERATION OF A USER INTERFACE BASED ON A RELATIONAL DATA MODEL - Technologies are described herein for generating a user interface based on a relational data model. A relational data model may be received. The relational data model may define a plurality of tables including a first table and a second table. The first table may include a first plurality of fields, and the second table may include a second plurality of fields. Relationships between the plurality of tables in the relational data model may be identified. A plurality of forms may be generated based on the relationships as identified. Each of the plurality of forms may correspond to one plurality of tables. The plurality of forms may be linked based on the relationship. The user interface including the plurality of forms as linked may be generated. | 03-13-2014 |
Robert Helal, Orleans CA
Patent application number | Description | Published |
---|---|---|
20080249815 | Adaptive analytics system and method of using same - An adaptive analytics system comprises a set of analytic type templates representing analytic types, each analytic type template including predetermined report items for generating a report for a respective analysis type; and an analytic framework for defining relations among the analytic types. The relations provides analytic paths for navigating reports. | 10-09-2008 |
20100070421 | DATA WAREHOUSE SYSTEM - A data warehouse system for managing performance of organizations is provided. The data warehouse system comprises a data model for storing data representing dimensions and measures applicable for multiple organizations, and a configuration unit for setting the placeholders such that the data model represents the particular organization. The data model has placeholders settable such that the data model represents a particular organization. | 03-18-2010 |